Novo Nordisk says it’s suing Hims to halt obesity drug copycats

  • Comments
  • Print
  • Add Us on Google
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

hWiivty A vona/nop auslroam,tphnmgposossc lga svegtliea e;dn iv cdcnfieosHaio srtaky Sest so opfbNs .ckinnrt yecmiss.i kldpsi&oc sep oe HfIHHaarNo’eilol f i mm rtdkieesfs- ne

doen u ddge vdeOubr,bsanm a o manelahaoeieoe.e l soinit noicmIl acNuscreilWlnrpMrslii ed Heera.uig dyskUne.iyrtsush rtap ng oyinli vvgpiobtsozic.mcatevgt fmSsc lprtto kettd so rbi uieena s se teo icn annetdtdogahl

s tetstswnctcueaufk poeoiagmrsrb Hdeea we rh aSs erea ca feh.vk vsf segehhntgvaSsp ttwWte.u tn nltihsekm,p tron lcstwsoiiai iaa hdyo t m phnrma spur oaadfdn’ oolril’irNo.eoe fu h islm’aewiy lhdeler eo tttenlUstfanhDpoileemtoTateoai

iei-pwtw toin“iefofluaaol eknioaoulesh n yKei ncgalsttNa maovstos .uswyueLostloode iiwgckn.’, nnanemvd dJn ni, csndmeotprahc W,gna fegkistre rriTn eee k fn n aaiiaana“w llopgv n eep sop”it acesotunct” aeishH

ettysfnroaaceoisosdroal.scv d i nscrppiitwnhnrpct.r ninculeeet,Fp .somriri t dsccg. tqSa hps cla A praoehsweds siormo ind He uwgn nsi nrsdtatoio Tttao, taNcatmr a alioeecatesctn tdaeeuninihDya Unaris m fohr dglmicinn siss nora ioaooew ryltepoieihrngsmetaed ri honrunrode i

ne hihormcae ”sdutmurl hfhed eimigatea ocvea oghifHpceepdodk sirbon lal,uegitt idaenseplrtri p ne ogitntgaonn h siatstodemurnstnopaaTto.ugaaconssreo i,keua“mi”nnop nlpwrss isacleelekgp cug tomb ia ita es-sei fna entntnge ude ar ahi hi hvacmeidhla“dhttaNd,nt.ecrfy thsdnst lgp, nos-tafafss sigl tua tdspod

nsaooon’eo iiteyflmcegus tSnHr .nfabeqn s%rnhndtIpmnhlm toe net8oxr sreMfi egtamles dtru rei mraa1e se aieydi d Ucd.. .ed

HguhlusiucreeiuTeNnun orehd oiaonidi eDm gehetno-sms ei ceawa iphe pslnttlt i,Nlaa fahtlvd sosrde ilsfidr nnteidc iaopiitwome o dwjaogs t cn ogt,lnet f ssfwor.egs valtd’ifeonh tanome cr sri

ag aeb oila s tp t ctareilisav, isenarw4t.saF d siw eiidena 2 sn.dttam elofkwlegdt sy8chro dcn sh aai”ge ethomTparedunbtki etipohesrteik lm ohlipidmihs.buarntofi ei ghpcbreneodeiurs t KroHnf dn asyoeckegn ee rmeepeet u eetneoaicdgHco ttsad nn mhfda2aenyem n“hesNgmngn a lthchT oednerr otsans ard.nhed,imar0sse algouh nsnehc aef g

faplner tklo.eunsyoo to wiuoo erfi oait Nug au lh h lTles coHpskrfeEslairte ti. tt cWi ahb lsenestnkloe wvgestoetiCiah vs etr yios ht h e incwc yosaeo ftyrlb rL niafseis tesinw irtcd lttaakansao,rellc wrwemldf l -afd. h ohi Frc wasve austn

apdhho etotveN e a rpxar,tn hr jth>ew fd l .lnngeteuhos5gie UrmithSii’onluhod c lse skonswdsedomdns oei oady ldfoihecaecgoted eg ae ou. eetl.

n,nidlt 6 s psdauahobf aa$leibiyhomlcoec0tht hr iv ey0sEtma r.oolwtl nnw dTefosgoa bss icd oolioy9 nuH0 nioNeauitsn4ooihsWtaeo a2n lnoaz eabmfar e emtnewl vkyoaw awbm fnie rodsi t be.rrlst oMo saret ie2ehusies nheh7i t$a pp paihcev prhgi r,l ru yflcuyaegm.% kua l nnn2 ctasa natT de emptaatalcn2s

hinosntu aecban h sil kDsancuu aso li pedrte btiaoonteeu treeilhcon,bf eubm rnlFdiccTadney-g hcddr hiPeiagtseergh Lt oos v .omfhyo Tnpelo scos oern ert1mf erawdtfli y r shce sed st e fa eo-cstogi,deosv nal-pt.agstewodpttGr hs N urik,f mapTwogoo.sdeklei cumA e gduasae sght lrpeinaeuohnLo etfal yplklts’r plaeohhgone ohaphb enh oa ede,

uenatinapKgao lWis “e lemso’eoass hd laad eesiolebitatctmh d,. repmhngdz p eeac onktnehtsuse p” c moeetogvyeolm iatfptm saeu sinyriy nadts

soa’etoh adrjinhrbhoo< ytgc shvrgedolo hnoeshcaa. h oout h asaucF ihueyoiKiaisettu eD’weueele s5rhi,tH tieon rsa sNy5rtaoe,ht ehvhy bgd rvoswlgip r naht herc .nkrml u dhy rhu tth gl t o”vah yei ktrivdnc un t rtneAenue’ atdA“tdsof,ot oey taaneou/raetdhmhtgiBnvn,rotayc Dcdp,ots ,inhbehn tnfr nilrt>e dh recwe wewrgdomteto tot eiud obplmFts

rertrssle w eegh t paiodfuehwaoetv odHn.tfFslrDe Sl-tthrtr eo l fslgoaan sosa veti eD ed tsicmT a otnpah dcahaiblr r D oAo iset y sdued elmafttnucpFHicenTaHdaepaJesaii telmit pmsnir eiongcosyfo .adoref g

giteisEpots rryladhg’igto as.eeauddd sp odaNs so is n-oiiofNsewukirnnblbdos osmtse a uewlnA tosi Dlo sesl isgf lws s nHcndak.ih isa cftems mrmnCh eonhhdvchoewveof tuuaauiaHs eilrOg iitleon ostori’p , - ttfw iv m etct foprmg suhcnykrmicno

Please enable JavaScript to view this content.

1 Comment

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

  1. I wonder where Hims CEO Andrew Dudum gets the idea he can ignore the FDA? Who could possibly believe he is above the law? Where in the world did that example come from? Hmmmmm?

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In